JPS61227579A - ホモシステインチオラクトン誘導体、その製法およびそれを含有する医薬 - Google Patents

ホモシステインチオラクトン誘導体、その製法およびそれを含有する医薬

Info

Publication number
JPS61227579A
JPS61227579A JP61038135A JP3813586A JPS61227579A JP S61227579 A JPS61227579 A JP S61227579A JP 61038135 A JP61038135 A JP 61038135A JP 3813586 A JP3813586 A JP 3813586A JP S61227579 A JPS61227579 A JP S61227579A
Authority
JP
Japan
Prior art keywords
amino
tetrahydro
oxo
carbonyl
thienyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP61038135A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0322878B2 (enExample
Inventor
パオロ・チエシ
ビツトリノ・セルバジオ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHIESHI PHARMACEUT SpA
Original Assignee
CHIESHI PHARMACEUT SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHIESHI PHARMACEUT SpA filed Critical CHIESHI PHARMACEUT SpA
Publication of JPS61227579A publication Critical patent/JPS61227579A/ja
Publication of JPH0322878B2 publication Critical patent/JPH0322878B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/36—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP61038135A 1985-02-22 1986-02-21 ホモシステインチオラクトン誘導体、その製法およびそれを含有する医薬 Granted JPS61227579A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT19621A/85 1985-02-22
IT8519621A IT1215238B (it) 1985-02-22 1985-02-22 Derivati di omocisteina tiolattone,loro procedimento di preparazione e formulazioni farmaceutiche

Publications (2)

Publication Number Publication Date
JPS61227579A true JPS61227579A (ja) 1986-10-09
JPH0322878B2 JPH0322878B2 (enExample) 1991-03-27

Family

ID=11159747

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61038135A Granted JPS61227579A (ja) 1985-02-22 1986-02-21 ホモシステインチオラクトン誘導体、その製法およびそれを含有する医薬

Country Status (8)

Country Link
US (1) US4690944A (enExample)
EP (1) EP0192191B1 (enExample)
JP (1) JPS61227579A (enExample)
AT (1) ATE42287T1 (enExample)
DE (1) DE3662887D1 (enExample)
ES (1) ES8708134A1 (enExample)
IT (1) IT1215238B (enExample)
PT (1) PT82071B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254530B (it) * 1992-03-18 1995-09-25 Derivati mercapto acetamidici
US5237057A (en) * 1992-04-06 1993-08-17 Biosite Diagnostics, Inc. Tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol derivative conjugates and labels
US5274122A (en) * 1992-10-15 1993-12-28 Merck & Co., Inc. Acidic derivatives of homocysteine thiolactone
ES2061398B1 (es) * 1993-03-02 1996-02-16 Prodesfarma Sa Procedimiento de obtencion de n-acetil homocisteina tiolactona a partir del dl-homocistina por metodos electroquimicos.
ES2061397B1 (es) * 1993-03-02 1996-02-16 Prodesfarma Sa Procedimiento de obtencion de n-acetil homocisteina tiolactona a partir de nn-acetil homocistina por metodos electroquimicos.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2129877B1 (enExample) * 1971-03-18 1974-08-02 Fuveau Sa
FR2265355B1 (enExample) * 1974-03-28 1977-11-04 Blum Jean
IT1068217B (it) * 1976-10-14 1985-03-21 Sigma Tau Ind Farmaceuti Omocisteina tiolattone 6 cloro nicotinamide
FR2502153A1 (fr) * 1981-03-19 1982-09-24 Rech Pharmaceutiq Medicale Acides (2-oxo-3-tetrahydrothienylcarbamoyl)-alkylthio) acetiques, leurs sels et leurs esters, leur procede de preparation et les compositions pharmaceutiques en contenant

Also Published As

Publication number Publication date
IT8519621A0 (it) 1985-02-22
ES8708134A1 (es) 1987-09-16
ATE42287T1 (de) 1989-05-15
US4690944A (en) 1987-09-01
EP0192191B1 (en) 1989-04-19
EP0192191A1 (en) 1986-08-27
PT82071A (en) 1986-03-01
JPH0322878B2 (enExample) 1991-03-27
IT1215238B (it) 1990-01-31
DE3662887D1 (en) 1989-05-24
ES552281A0 (es) 1987-09-16
PT82071B (pt) 1987-12-30

Similar Documents

Publication Publication Date Title
EP0506532B1 (fr) Nouveaux dérivés de l'indole, procédé de préparation et médicaments les contenant
FR2530626A1 (fr) Composes de carbostyryle
EP0630894A1 (en) Propenoic acid derivatives as adenosine A1 antagonists
EP1369419B1 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
JPH01190688A (ja) ピロリチジン化合物およびその用途
KR900006118B1 (ko) 4-퀴놀론 유도체의 제법
JP2007516950A (ja) プロスタグランジンｅ２アゴニストまたはアンタゴニストであるオルニチン誘導体
JPS61227579A (ja) ホモシステインチオラクトン誘導体、その製法およびそれを含有する医薬
LU86421A1 (fr) Derives de piperazine 1,4-disubstitues,composition pharmaceutique les contenant;leur procede d'obtention
EP0463944B1 (fr) Acyl benzoxazolinones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
FR2505834A1 (fr) Derives de la thiazolidine
JPH07267954A (ja) 新規の３−フェニルスルホニル−３，７−ジアザビシクロ［３，３，１ノナン−化合物、その製法及び抗不整脈剤
CN113402414A (zh) 一种苯甲酸衍生物及其制法和药物用途
EP2917204B1 (fr) Derives de 1h-indole-3-carboxamide et leurs utilisation comme antagonistes du p2y12
HU181608B (en) Process for producing imidazo-thieno-pyrimidine derivatives
JPS62120375A (ja) チアゾリジン誘導体、その製法および医薬組成物
EP0773019A1 (en) Hyperlipemia remedy
WO2019232664A1 (zh) 一类具有消炎免疫活性的磺酰基取代呋喃类化合物及其衍生物
CN103145673B (zh) 黄豆苷元衍生物及其药学上可接受的盐
CA1164862A (en) Indol acetic derivates, process for producing the same and pharmaceutical compositions comprising the same
JP3049284B2 (ja) ヒダントイン誘導体並びにそれを有効成分とする糖尿病合併症及び循環器系疾患の予防及び治療剤
CN111662239A (zh) 1,2,4-三唑类化合物及其制法和药物用途
KR870000497B1 (ko) N, 3-이치환된 2-옥시인돌-1-카복사마이드의 제조방법
LU82434A1 (fr) Procede de preparation de derives condenses de la pyrimidine,les sels,hydrates et isomeres de ceux-ci,certains representants de ces composes prepares et compositions pharmaceutiques contenant ceux-ci
JPH0499770A (ja) ロダニン誘導体